Search Results - "MENICHETTI, A"

Partial splenic embolization in chemotherapy-induced thrombocytopenia: a retrospective analysis with long term follow up by Procaccio, L, Schirripa, M, Aliberti, C, Bergamo, F, Dadduzio, V, Finotto, S, Loupakis, F, Menichetti, A, Zagonel, V

Get full text

Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy? by Gadducci, A, Notarnicola, M, Menichetti, A, Lanfredini, N, Fanucchi, A, Cosio, S

“…To correlate serum CA125 at relapse with survival in ovarian cancer patients who achieved a complete response after primary cytoreduction and paclitaxel- and…”
Get more information

Mechanical Circulatory Support in Advanced Heart Failure: Single-Center Experience by Loforte, A, Montalto, A, Lilla della Monica, P, Lappa, A, Contento, C, Menichetti, A, Musumeci, F

“…Abstract Background Currently, ventricular assist device (VAD) or total artificial heart (TAH) mechanical support provides an effective treatment of unstable…”
Get full text

Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock by Loforte, A, Pilato, E, Martin-Suarez, S, Montalto, A, Lilla Della Monica, P, Potena, L, Grigioni, F, Marinelli, G, Frascaroli, G, Menichetti, A, Musumeci, F, Arpesella, G

“…Purpose The RotaFlow (Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) and Levitronix CentriMag (Levitronix LCC, Waltham, MA) as central or peripheral…”
Get full text

Treatment with daptomycin for Corynebacterium Jeikeium left-sided prosthetic valve endocarditis by Lappa, A, Donfrancesco, S, Picozzi, P, Vitozzi, T, Marrapodi, A, Menichetti, A, Casali, G, Musumeci, F

“…Prosthetic valve endocarditis (PVE) is a serious complication with potential fatal consequences, classified as early or late PVE, depending on whether typical…”
Get full text

Mitral valve replacement under thoracic epidural anesthesia in an awake patient suffering from systemic sclerosis by Picozzi, P., Lappa, A., Menichetti, A.

Get full text

122P Abemaciclib in HR+/HER2- metastatic breast cancer: A real-world experience by Bottosso, M., Giarratano, T., Barbieri, C., Menichetti, A., Cumerlato, E., Miglietta, F., Genovesi, E., Amato, O., Dieci, M.V., Griguolo, G., Guarneri, V.

Get full text

227P Peripheral blood lymphocyte counts predict clinical outcomes in patients with hormone receptor-positive HER2-negative advanced breast cancer treated with CDK4/6 inhibitors by Vernieri, C., Zattarin, E., Mariani, L., Menichetti, A., Leporati, R., Ligorio, F., Fuca, G., Lobefaro, R., Griguolo, G., Sirico, M., Bernocchi, O., Marra, A., Agostinetto, E., Jacobs, F., di Mauro, P., Curigliano, G., Pedersini, R., Losurdo, A., Generali, D., Dieci, M.V.

Get full text

Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid by Menichetti, A, Tritapepe, L, Ruvolo, G, Speziale, G, Cogliati, A, Di Giovanni, C, Pacilli, M, Criniti, A

“…Cardiopulmonary bypass (CPB) increases risk of postoperative bleeding and need for transfusion. The aim of this study was to evaluate the effects of aprotinin,…”
Get more information

99P Association of gut microbiome diversity and composition with pathological complete response (pCR) after neoadjuvant chemotherapy in triple negative breast cancer by Vernaci, G., Cumerlato, E., Griguolo, G., Massa, D., Menichetti, A., Miglietta, F., Tasca, G., Savarino, E., Conte, P.F., Guarneri, V., Dieci, M.V.

Get full text

138P Predicted cumulative risk of late relapse in HR-positive/HER2-negative BC: A competing risk analysis of a real-world population by Vernaci, G.M., Girardi, F., Zampieri, D., Menichetti, A., Cattelan, A.C., Falci, C., Faggioni, G., Dieci, M.V., Cortese, G., Guarneri, V.

Get full text

High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting by Mercieri, M, Mercieri, A, Tritapepe, L, Ruggeri, M, Arcioni, R, Repetto, M, Bottari, B, Menichetti, A

“…Both aprotinin and gentamicin-vancomycin antibiotic prophylaxis have been used widely in cardiac surgery to prevent bleeding and infections, respectively. As…”
Get full text

BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis by Vernaci, Grazia, Dieci, Maria Vittoria, Manfrin, Silvia, Mantiero, Mara, Falci, Cristina, Faggioni, Giovanni, Mioranza, Eleonora, Menichetti, Alice, Tasca, Giulia, Griguolo, Gaia, Miglietta, Federica, Di Liso, Elisabetta, Saibene, Tania, Michieletto, Silvia, Ghiotto, Cristina, Conte, Pierfranco, Guarneri, Valentina

“…•BMI negatively affects breast cancer survival.•Higher BMI is associated with older age, post-menopausal status and advanced stages.•Obese patients experience…”
Get full text

Nosocomial infections in heart surgery patients: active surveillance in two Italian hospitals by Sodano, L, Agodi, A, Barchitta, M, Musumeci, F, Menichetti, A, Bellocchi, P, Cunsolo, R, Coco, G

“…In Italy no nosocomial infection surveillance database has been established despite the fact that a decrease of nosocomial infection rates was one of the…”
Get more information

192PCarboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study by Dieci, M V, Giorgi, C A, Griguolo, G, Angelini, S, Miglietta, F, Giarratano, T, Falci, C, Faggioni, G, Tasca, G, Mioranza, E, Vernaci, G, Menichetti, A, Mantiero, M, Genovesi, E, Frezzini, S, Saibene, T, Michieletto, S, Guarneri, V

“…Abstract Background The value of adding carboplatin (Cb) to neoadjuvant chemotherapy for TNBC is debated. Current evidence supports the association between Cb…”
Get full text

192P - Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study by Dieci, M.V., Giorgi, C.A., Griguolo, G., Angelini, S., Miglietta, F., Giarratano, T., Falci, C., Faggioni, G., Tasca, G., Mioranza, E., Vernaci, G., Menichetti, A., Mantiero, M., Genovesi, E., Frezzini, S., Michieletto, S., Guarneri, V., Saibene, T.

“…The value of adding carboplatin (Cb) to neoadjuvant chemotherapy for TNBC is debated. Current evidence supports the association between Cb use and increased…”
Get full text

Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study by Dieci, M.V., Giorgi, C.A., Griguolo, G., Angelini, S., Miglietta, F., Giarratano, T., Falci, C., Faggioni, G., Tasca, G., Mioranza, E., Vernaci, G., Menichetti, A., Mantiero, M., Genovesi, E., Frezzini, S., Michieletto, S., Guarneri, V., Saibene, T.

Get full text

Abstract P6-18-24: Lapatinib-based therapies after pertuzumab and/or T-DM1 for HER2+ metastatic breast cancer patients by Frezzini, S, Giarratano, T, Dieci, MV, Giorgi, CA, Griguolo, G, Vernaci, G, Menichetti, A, Mantiero, M, Tasca, G, Faggioni, G, Falci, C, Miglietta, F, Mioranza, E, Angelini, S, Ghiotto, C, Conte, P, Guarneri, V

“…Background: Trastuzumab + pertuzumab + taxane and ado-trastuzumab emtansine (T-DM1) are standard first and second-line therapies for HER2+ metastatic breast…”
Get full text

168P Development of a combined clinical model to predict progression-free survival (PFS) in advanced breast cancer (ABC) treated with CDK4/6 inhibitors (CDK4/6i) by Martínez-Sáez, O., Menichetti, A., Pare Brunet, L., Griguolo, G., Rodriguez Hernandez, A., Pascual, T., Dieci, M.V., Conte, P.F., Giorgi, C.A., Brasó-Maristany, F., Chic, N., Martínez, D., Rodríguez, A., Schettini, F., Conte, B., Vidal, M., Adamo, B., Muñoz, M., Prat, A., Guarneri, V.

Get full text

Robotic assisted mitral valve repair: early experience with the da Vinci S robotic system by Mega, S., Bono, M. C., Castiglione, I., Ranocchi, F., Casacalenda, A., Contento, C., Menichetti, A., Patti, G., Di Sciascio, G., Musumeci, F.

Get full text